How Teva’s Generic Medicines Business Is Positioned after 3Q17

Teva's Generic Medicine segment generated 3Q17 revenues of $3.0 billion, which was ~8% higher YoY (year-over-year) but ~2% lower QoQ (quarter-over-quarter).